Hunt BioVentures
2
38M
2
0.10
1
- Stages of investment
- Areas of investment
Summary
Hunt BioVentures is the famous VC, which was founded in 2001. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Dallas.
The top amount of exits for fund were in 2013. The top activity for fund was in 2012. The fund is generally included in less than 2 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Biotechnology, Innovation Management. Among the most popular portfolio startups of the fund, we may highlight OvaScience, Morphotek.
The typical case for the fund is to invest in rounds with 7-8 participants. Despite the Hunt BioVentures, startups are often financed by CB Health Ventures, Burrill & Company, Turnbridge Capital. The meaningful sponsors for the fund in investment in the same round are SR One, Rock Maple Ventures, RA Capital Management.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.10
- Investments by industry
- Biotechnology (2)
- Innovation Management (1)
- Medical (1)
- Life Science (1)
- Health Care (1)
- Investments by region
-
- United States (2)
- Peak activity year
- 2012
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Avg. valuation at time of investment
- 5M
- Group Appearance index
- 1.00
- Avg. company exit year
- 7
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| OvaScience | 03 Apr 2012 | Biotechnology, Health Care, Life Science | Early Stage Venture | 37M | United States, Massachusetts, Boston |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.